Mahalaxmi Mohan

Dr. Mahalaxmi Mohan

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MMMahalaxmi Mohan
Mahalaxmi Mohan
SKSarika Kamble
Sarika Kamble
PGPrakash Gadhi
Prakash Gadhi
SKSanjay Kasture
Sanjay Kasture

23 March 2009 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RTRoshan Tiwari
Roshan Tiwari
MMMahalaxmi Mohan
Mahalaxmi Mohan
SKSanjay Kasture
Sanjay Kasture
Andrea MaxiaAndrea Maxia
Andrea Maxia
MBMauro Ballero
Mauro Ballero

17 June 2010 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MMMahalaxmi Mohan
Mahalaxmi Mohan
HWHarshal Waghulde
Harshal Waghulde
SKSanjay Kasture
Sanjay Kasture

7 March 2011 in Natural Product Research
Verified
Journal Article
Closed access
PBPravin Borde
Pravin Borde
MMMahalaxmi Mohan
Mahalaxmi Mohan
SKSanjay Kasture
Sanjay Kasture
Chronic administration of myricetin (100 and 300 mg kg−1, p.o., for 4 weeks) isolated from Vitis vinifera (Vitaceae) ameliorated hypertension and oxidative stress induced by deoxycorticosterone acetate (DOCA)-salt in rats. Myricetin treatment reduced systolic blood pressure, vascular reactivity changes and reversed the DOCA-induced increase in heart rate. Urinary sodium excretion was significantly decreased in animals treated with myricetin compared to the DOCA group when measured by flame photometer. The cumulative concentration response curve of serotonin (5-HT) and angiotensin II (Ang II) were shifted towards the right in rats treated with myricetin using the isolated rat fundus strip and ascending colon, respectively. Increased levels of thiobarbituric acid reactive substances and decreased levels of superoxide dismutase, catalase and reduced glutathione in the heart tissue were observed in animals treated with DOCA, which were reversed by myricetin. Thus, myricetin shows antihypertensive and antioxidant properties in the DOCA model of hypertension.

19 April 2010 in Pharmaceutical Biology
Verified
Journal Article
Open access
PDF file
SGSandip Godse
Sandip Godse
MMMahalaxmi Mohan
Mahalaxmi Mohan
VKVeena Kasture
Veena Kasture
SKSanjay Kasture
Sanjay Kasture
Fructose feeding induces a rise in blood pressure in normal rats and is associated with insulin resistance, hyperinsulinemia, and hypertriglyceridemia. We have examined the effect of myricetin (100 and 300 mg/kg, p.o. for 6 weeks) isolated from Vitis vinifera Linn. (Vitaceae) on systolic blood pressure (SBP), vascular reactivity, serum glucose, triglycerides, cholesterol, and insulin in fructose-induced hypertension. Myricetin reduced systolic blood pressure and vascular reactivity changes to catecholamines and reversed the metabolic alterations induced by fructose. The cumulative concentration–response curve (CCRC) of Ang II was shifted toward the right in rats treated with myricetin, using isolated strips of ascending colon. The results suggest that myricetin could prevent the development of high blood pressure induced by a diet rich in fructose, probably by reversing the metabolic alterations induced by fructose. In conclusion, myricetin has antihypertensive action in the fructose model.

1 October 2009 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MMMahalaxmi Mohan
Mahalaxmi Mohan
BJBhagat Singh Jaiswal
Bhagat Singh Jaiswal
SKSanjay Kasture
Sanjay Kasture